SB

Shivaji Baburao Patil

Active Director Director DIN 09513070
DIN 09513070 First appointment Feb 2022 Primary industry Machinery and Equipment
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Shivaji Baburao Patil

Data last updated:

Shivaji Baburao Patil is a Director at Sustime Pharma Limited (since 2022). The company operates in Machinery and Equipment. Sustime Pharma Limited reported revenue of ₹5,902 (FY 2024).

DIN 09513070
Primary Designation Director
Industry Machinery and Equipment
First Appointment 21 Feb 2022
Oldest Company Age 34 yrs
Largest company Sustime Pharma Limited · ₹5,902 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sustime Pharma Limited U24230MH1992PLC065589
Director21 Feb 20221992₹5,902 (FY 2024)Active

Board colleagues of Shivaji Baburao Patil

Directorship timeline

Open interactive timeline →
Sustime Pharma Limited
Premium access

Shareholding and investment profile for Shivaji Baburao Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shivaji Baburao Patil

Shivaji Baburao Patil currently holds 1 directorship: Sustime Pharma Limited (Director, since 21 Feb 2022, revenue ₹5,902 (FY 2024)).

Shivaji Baburao Patil was first appointed on 21 Feb 2022 as Director at Sustime Pharma Limited.

The current boards of Shivaji Baburao Patil's companies include Kaushik Kantilal Shah (Sustime Pharma Limited), Sheela Nirmal Bhogilal (Sustime Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available